Evidence map›Paper›PMID 37071682›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2023

Cross-linking mass spectrometry discovers, evaluates, and corroborates structures and protein-protein interactions in the human cell.

Tara K Bartolec, Xabier Vázquez-Campos, Alexander Norman, Clement Luong, Marcus Johnson, Richard J Payne, Marc R Wilkins, Joel P Mackay, Jason K K Low

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Discovery of Glycation-Derived Cross-links at Arginine.Journal of the American Chemical Society · 2026
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. State-of-the-Art and Future Directions in Structural Proteomics.Molecular & cellular proteomics : MCP · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Tara K BartolecSystems Biology Initiative, School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Randwick, NSW 2052, Australia.ORCID 0000-0002-5291-6972
Xabier Vázquez-CamposSystems Biology Initiative, School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Randwick, NSW 2052, Australia.ORCID 0000-0003-1134-5058
Alexander NormanSchool of Chemistry, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0001-7908-0135
Clement LuongSchool of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0002-5479-2301
Marcus JohnsonSchool of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0009-0008-3137-3084
Richard J PayneSchool of Chemistry, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0002-3618-9226
Marc R WilkinsSystems Biology Initiative, School of Biotechnology and Biomolecular Sciences, The University of New South Wales, Randwick, NSW 2052, Australia.ORCID 0000-0002-5700-5684
Joel P MackaySchool of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0001-7508-8033
Jason K K LowSchool of Life and Environmental Sciences, University of Sydney, Sydney, NSW 2006, Australia.ORCID 0000-0003-0862-0012

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Significant recent advances in structural biology, particularly in the field of cryoelectron microscopy, have dramatically expanded our ability to create structural models of proteins and protein complexes. However, many proteins remain refractory to these approaches because of their low abundance, low stability, or-in the case of complexes-simply not having yet been analyzed. Here, we demonstrate the power of using cross-linking mass spectrometry (XL-MS) for the high-throughput experimental assessment of the structures of proteins and protein complexes. This included those produced by high-resolution but in vitro experimental data, as well as in silico predictions based on amino acid sequence alone. We present the largest XL-MS dataset to date, describing 28,910 unique residue pairs captured across 4,084 unique human proteins and 2,110 unique protein-protein interactions. We show that models of proteins and their complexes predicted by AlphaFold2, and inspired and corroborated by the XL-MS data, offer opportunities to deeply mine the structural proteome and interactome and reveal mechanisms underlying protein structure and function.

Indexed as

Molecular BiologyProteomicsCross-Linking ReagentsCryoelectron MicroscopyHumansMass SpectrometryProteomeCross-Linking ReagentsProteomeAlphaFold2cross-linking mass spectrometryprotein–protein interactionsprotein structure predictionstructural proteomics

Identifiers

PMID37071682
PMCPMC10151615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.